To begin the physical characterization of eukaryotic initiation factor (eIF) 2A, a translation initiation factor that binds Met-tRNA i , tryptic peptides from rabbit reticulocyte eIF2A were analyzed to obtain amino acid sequence information. Sequences for 8 peptides were matched to three different expressed sequence tag clones. The sequence predicted for eIF2A is 585 amino acids. Matching of the cDNA sequence to the human genome revealed that the eIF2A mRNA is made up of 15 or 16 exons, and the gene is contained on chromosome 3. A homolog in Saccharomyces cerevisiae was identified, YGR054W, which is a non-essential gene. Hemagglutinin-tagged yeast eIF2A localizes on both 40 S and 80 S ribosomes. A knockout of both eIF2A and eIF5B yielded a "synthetically sick" yeast strain with a severe slow growth phenotype. The phenotype of this double mutant and the biochemical localization suggest that eIF2A participates in translation initiation. eIF2A does not appear to participate in re-initiation as the ⌬eIF2A strain shows the same level of GCN4 induction with amino acid starvation as seen in wild type yeast. The lack of any apparent phenotype in the ⌬eIF2A strain suggests that eIF2A functions in a minor pathway, perhaps internal initiation or in the translation of a small number of specific mRNAs.
To begin the physical characterization of eukaryotic initiation factor (eIF) 2A, a translation initiation factor that binds Met-tRNA i , tryptic peptides from rabbit reticulocyte eIF2A were analyzed to obtain amino acid sequence information. Sequences for 8 peptides were matched to three different expressed sequence tag clones. The sequence predicted for eIF2A is 585 amino acids. Matching of the cDNA sequence to the human genome revealed that the eIF2A mRNA is made up of 15 or 16 exons, and the gene is contained on chromosome 3. A homolog in Saccharomyces cerevisiae was identified, YGR054W, which is a non-essential gene. Hemagglutinin-tagged yeast eIF2A localizes on both 40 S and 80 S ribosomes. A knockout of both eIF2A and eIF5B yielded a "synthetically sick" yeast strain with a severe slow growth phenotype. The phenotype of this double mutant and the biochemical localization suggest that eIF2A participates in translation initiation. eIF2A does not appear to participate in re-initiation as the ⌬eIF2A strain shows the same level of GCN4 induction with amino acid starvation as seen in wild type yeast. The lack of any apparent phenotype in the ⌬eIF2A strain suggests that eIF2A functions in a minor pathway, perhaps internal initiation or in the translation of a small number of specific mRNAs.
Eukaryotic initiation factor 2A (eIF2A) 1 is a 65-kDa protein that catalyzes the formation of puromycin-sensitive 80 S preinitiation complexes and the poly(U)-directed synthesis of polyphenylalanine at low [Mg 2ϩ ] (1). When eIF2A was initially identified, it was believed to be the functional homolog of prokaryotic IF2, because IF2 catalyzes similar reactions. One slight difference was that eIF2A would catalyze polyphenylalanine synthesis at low [Mg 2ϩ ] with Phe-tRNA E. coli but not PhetRNA from eukaryotic sources. Subsequent identification of eIF2 led to the functional comparison of the eIF2A and eIF2.
Unlike IF2 or eIF2A, eIF2 was unable to catalyze poly(U)-directed polyphenylalanine synthesis, although it could direct the formation of puromycin-sensitive 80 S preinitiation complexes with Met-tRNA i (2) . eIF2A and IF2 have been shown to bind initiator tRNA in a GTP-independent manner, but require the presence of the small ribosomal subunit and the trinucleotide start codon, AUG. In contrast, eIF2 formed a ternary complex composed of Met-tRNA i and GTP, a step that did not require AUG (3) . Both eIF2 and eIF2A were active in the methionyl-puromycin synthesis assay and have the same complementary factor and nucleotide requirements (eIF1A, eIF5A, eIF5B, and GTP). eIF2 was found to out-compete eIF2A in the methionyl-puromycin synthesis assay when both proteins were present (4) .
Although both eIF2 and eIF2A function in the methionylpuromycin assays, the order of events differed between the two. eIF2A binds Met-tRNA i to 40 S subunits in a codon-dependent manner, whereas eIF2 binds Met-tRNA i to 40 S subunits in a GTP-dependent manner. Although eIF2A binds Met-tRNA i to 40 S subunits and is assumed to interact with the 40 S subunit, no subunit complex has been identified with eIF2A bound to the subunit. Both factors required eIF5B, eIF1A, and eIF5A to catalyze methionyl-puromycin synthesis. The GTP requirement for both pathways in methionyl-puromycin synthesis was investigated (5) . The eIF2 pathway has an apparent K m for GTP of 1.1 M, whereas the pathway using eIF2A resulted in an apparent K m of 12.6 M. Thus, in the eIF2 pathway, eIF2 binds GTP as part of the ternary complex, eIF2⅐GTP⅐Met-tRNA i . In the eIF2A pathway, the likely factor that binds GTP is eIF5B, because this factor has a K m of ϳ10 M for GTP as determined by the ribosome-dependent GTPase assay (6) . With these assays, it was also shown that eIF2 could form methionyl-puromycin without the addition of extra GTP; therefore, one GTP was all that was required for eIF2-directed 80 S complex formation (5) .
In assays that utilized natural mRNA in place of the trinucleotide AUG, eIF2A was not found to be active, and thus eIF2 was considered the initiation factor responsible for directing the binding of initiator tRNA to the P-site (4). Since the only purified mRNA available at the time was globin mRNA, eIF2A was not tested with different cellular or viral mRNAs. With the discovery of a variety of alternative pathways for eukaryotic initiation (i.e. internal initiation, re-initiation, non-AUG initiation, etc.; Ref. 7) it was of interest to determine whether eIF2A might play a role in these atypical initiation events.
In this study, the first step toward understanding the role of eIF2A in initiation was to determine the amino acid sequence of tryptic fragments of eIF2A. These sequences were then com- pared with those available in the protein data base. Partial sequences were identified in human EST clones. Complete sequencing of these clones allowed for the generation of the complete eIF2A sequence. From this human eIF2A sequence, a yeast homolog was identified. Yeast strains were obtained that lacked the gene for eIF2A. These ⌬eIF2A strains were viable and showed no growth rate phenotype, although they sporulated about a third as well as wild type. By using an HA-tagged eIF2A, eIF2A was found associated with both 40 S subunits and 80 S ribosomes, but little or no eIF2A was present in polysomes.
MATERIALS AND METHODS
The following reagents were commercially available: Escherichia coli tRNA (Miles); BamHI, HindIII, and XhoI restriction enzymes (New England Biolabs); non-treated rabbit reticulocyte lysates (Green Hectares); trichloroacetic acid (Pierce); poly(U) (Amersham Biosciences); pyruvate kinase and phosphoenolpyruvate (Calbiochem); DNA oligonucleotides (Case Western Reserve University Molecular Biology Core Facility); nucleotide triphosphates (Sigma); and sulfometuron methyl (Chem Service).
Purification of Rabbit Reticulocyte Initiation Factor 2A-eIF2A was purified from commercially available rabbit reticulocyte lysate in one of two ways. The original purification was as described previously (1) and involved the sequential use of ammonium sulfate fractionation (0 -70%), DEAE-cellulose chromatography, Sephadex G200 size-exclusion chromatography, phosphocellulose chromatography, and finally, Sephadex G-100 size-exclusion chromatography. Activity of eIF2A was monitored using the low [Mg 2ϩ ] poly(U)-directed synthesis of polyphenylalanine assay, and protein purity was monitored using SDS-gel electrophoresis (see below).
For the eIF2A preparations recovered by an alternative purification protocol (8) , the purification of eIF2A from the ribosomal salt wash involved sequentially phosphocellulose chromatography, sucrose gradient sedimentation, ACA 34 size-exclusion chromatography, Sephadex G-75 size-exclusion chromatography, CM-cellulose chromatography, and Sephadex G-100 size-exclusion chromatography. Final purity of the eIF2A preparations was comparable using either of these purification schemes.
Low [MgCl 2 ] Poly(U)-directed Polyphenylalanine Synthesis AssayThis derivative of the poly(U)-directed polyphenylalanine synthesis assay is sensitive to the activity of initiation factors. Assays were performed as described previously (9) . Each 50-l reaction contained 1 g of eEF2, 3 g of eEF1A, 2 g of eIF1A, 2 g of eIF5A, 0.2 g of eIF5B, 2.0 g of eIF2A (or aliquots from column fractions), 4 mM MgCl 2 , 100 mM KCl, 10 pmol of Phe-tRNA (E. coli), 0.5 of A 260 of sucrose cushioned ribosomes, 0.1 unit of pyruvate kinase, 2 mM phosphoenolpyruvate, 1 mM GTP, 20 mM Tris-HCl (pH 7.5), 0.2 A 260 poly(U), and 1 mM dithiothreitol. The reaction was allowed to proceed at 37°C for 15 min. Incorporation of [ 14 C]Phe into polyphenylalanine was determined as hot trichloroacetic acid-precipitable radioactivity collected on nitrocellulose filters (Millipore, type HA) for scintillation counting.
Tryptic Digestion of Protein in Polyacrylamide Gel Slices-After gel electrophoresis, staining with Coomassie Blue, and destaining, the protein band of interest was excised from the gel, divided into small pieces, and destained in 50% methanol, 5% acetic acid in water overnight. The destain was changed once. Gel pieces were then dehydrated by the addition of acetonitrile, which was removed by lyophilization. Gel pieces were then reduced by the addition of 100 l of 10 mM dithiothreitol for 1 h at 55°C. Dithiothreitol was removed and the sample alkylated in 100 l of 50 mM iodoacetamide for 30 min. The sample was washed with ammonium bicarbonate, then dehydrated with acetonitrile twice, and dried. Gel pieces were then rehydrated in 50 -100 l of a 20 g/ml trypsin solution. Digestion was allowed to precede overnight at 37°C. Peptides were extracted twice in 200 l of 5% formic acid, 50% acetonitrile and pooled. The sample was then lyophilized to less than 25 l, but not to complete dryness, and analyzed by liquid chromatography-electrospray ionization tandem mass spectrometry (10) . These experiments were performed by Dr. Michael Kinter of the University of Virginia as a fee for service.
SDS-PAGE, Autoradiography, and Western Blot Analysis-SDS sample buffer (10% glycerol, 2% SDS, 40 mM Tris-HCl (pH 6.8), 1 mM dithiothreitol, and 0.02% bromphenol blue) was added at equal volume to samples for electrophoresis. The samples were heated to 90°C for 5 min prior to loading. The samples were then subjected to gel electrophoresis through a 12.5% acrylamide, 0.11% bisacrylamide gel in a Tris glycine (pH 8.3) buffer system as described previously (11) . Protein bands were identified by staining the gel with Coomassie Blue.
For Western blots, following SDS-PAGE, proteins were transferred onto a nylon membrane (Immobilon P, Millipore) using a transfer apparatus (4 h at 6 V) according to the method of Towbin et al. (12) . Immobilized proteins were exposed to rabbit polyclonal antiserum raised against either a peptide sequence from the human hIF2 (eIF5B) sequence or rabbit polyclonal antiserum raised against yeast eIF2␣ (generous gifts from Dr. Thomas Dever, National Institutes of Health) or goat polyclonal antiserum raised against eIF2 purified from rabbit reticulocytes. Detection of immunoreactive proteins was performed using a horseradish peroxidase-coupled secondary antibody and the ECL system (Bio-Rad).
Plasmid Preparation-All plasmid preparations were performed as indicated in the instructions for Qiagen mini-preparation protocols. Glycerol stocks (70% glycerin) for each strain were maintained at the vapor temperature of liquid nitrogen. Restriction enzyme analysis was performed as indicated for each enzyme by the manufacturer.
Northern Blot Analysis-Commercially available multiple human tissue RNA blots were obtained from and probed as indicated by the manufacturer (CLONTECH). A probe specific for the eIF2A sequence was synthesized by random primer methodology utilizing a 1.5-kbp insert from the human EST clone 327130. The plasmid was digested with XhoI and HindIII. This DNA fragment was isolated by subjecting it to electrophoresis through low-melt agarose, visualizing the band stained with ethidium bromide by exposing the gel to UV light, and excising the 1.5-kbp fragment. Fifty nanograms of this fragment, still contained within the agar, was used as the template for random-primed Klenow reactions using the Prime-A-Gene labeling kit as described by the manufacturer (Invitrogen). The radiolabeled probe was purified by size-exclusion chromatography and added to the hybridization buffer to be used to probe a multiple human tissue blot. After blotting and washing according to the manufacturer's protocol, the Northern blot was analyzed by autoradiography and band intensity determined by densitometry.
DNA Sequencing-DNA sequencing was performed by either the Molecular Biology Core Laboratory at Case Western Reserve University or the Molecular Biology Core Laboratory at the Cleveland Clinic Foundation. Sequencing was performed using either commercially available T7 promoter primers or custom-synthesized oligonucleotides using the fluorescently labeled dideoxy terminator methodology.
Yeast Strains-The following yeast strains were used in this report: J140 (MATa, ura3-52, leu2-3, leu2-112, fun12::LEU2), a generous gift from Dr. Thomas Dever (NICHD, National Institutes of Health);
Yeast Methods-Yeast cultures were grown as indicated using either synthetic medium containing 0.67% Difco yeast nitrogen base, 1% ammonium sulfate, 2% glucose and supplemented with the appropriate amino acids or complete medium (13) . Yeast were grown in the appropriate medium at 30°C to log phase. Transformation was done using the lithium acetate method (14) . For expression of HA-tagged eIF2A, yeast were grown in complete medium with 2% glucose, washed three times, and then shifted to complete medium with 2% galactose for 7 h before harvesting. To determine doubling times, all strains were diluted into complete media and the A 600 were taken every 2-4 h until they reached stationary phase. The results are an average of at least three independent measurements.
Expression of GCN4-lacZ Fusion Constructs in Yeast-p180, p196, p226, and p227 plasmids (15) derivatives of YCp50 (CEN, URA3) vector bearing different GCN4-lacZ alleles under the control of the GAL1 promoter were kindly provided by Dr. Thomas Dever (National Institutes of Health). Plasmids were transformed into isogenic yeast (BY4741) or eIF2A⌬ strains. For assays, cells were grown in a minimal synthetic (SD) medium supplemented with appropriate amino acids, containing 2% galactose for 2 h. To invoke amino acid starvation, sulfometuron methyl (stock solution of 2 mg/ml in Me 2 SO) was added to a final concentration of 0.5 g/ml, and the incubation was continued for an additional 4.5 h. Cells were harvested, and lacZ activity was measured following the protocol described in CLONTECH Yeast Protocols Handbook using O-nitrophenyl ␤-D-galactopyranoside as a substrate. Cell extracts were prepared by subsequent cycles of cell freezing in liquid nitrogen and thawing them at 37°C.
Constructs-The yeast eIF2A gene was obtained by PCR from genomic DNA from the strain BY4743 from ResGen. The primers used were 5Ј-GGTTCAATAACACGGATCCATTATGTCATCTCAG-3Ј (the 5Ј primer) and 5Ј-GTATGGATCCTGCAGTTTCTTCTAGTTTATTC-3Ј (the 3Ј primer), and the product was incorporated at the 5Ј BamHI site to clone in-frame with the HA tag in the pTB328 Gal-HA-leu2 vector which is YCplac111galp, CEN, LEU2, GAL1 promoter, HA tag (originally constructed by Dr. Thomas Beck in Dr. Michael Hall's laboratory (Ref. 16) , and a generous gift from Dr. Sandra Lemmon, Case Western Reserve University).
Fractionation of Ribosomes-All procedures were performed at 4°C except where indicated. Yeast cells from 50 ml of log phase culture were pelleted, treated for 1 min with 10 g/ml cycloheximide (Calbiochem), and repelleted. Lysates were made by bead-beating the yeast for 4 min, with intermittent cooling on ice, in polysome buffer that contained 100 mM KCl, 2 mM magnesium acetate, 20 mM HEPES-KOH (pH 7.4), 14.4 mM ␤-mercaptoethanol, 100 g/ml cycloheximide. This mixture was centrifuged at 5000 rpm for 8 min, and the supernatant was removed. 5-10 A 254 units were layered onto a 16.2-ml 10 -50% sucrose gradient containing 100 mM KCl, 5 mM MgCl 2 , 20 mM HEPES-KOH (pH 7.4), and 2 mM dithiothreitol. Lysates were sedimented in a Beckman SW28.1 rotor at 27,000 rpm for 4.5 h. Gradients were collected with continuous monitoring at 254 nm using an ISCO UA-5 absorbance detector and 1640 gradient collector. Samples run over 10 -25% gradients were sedimented in a Beckman SW28.1 rotor at 20,000 rpm for 16.5 h. Pellets were resuspended in polysome buffer, and supernatant fractions were either collected as above or pooled where indicated.
For Western blots from gradient fractions, yeast were grown in galactose-containing media overnight until they were in mid-log phase, and fractionation was performed as above. Proteins collected from sucrose gradient fractions were precipitated with 10% cold trichloroacetic acid, washed twice in 100 mM Tris-HCl (pH 8.0) and acetone (1:5, v/v), and solubilized by boiling in SDS sample buffer for 5 min. Pellets from 10 -25% gradients were resuspended in polysome buffer for immunoprecipitation or in SDS sample buffer. Equal amounts of each fraction were separated on 10% SDS-PAGE and transferred as above to Immobilon (Millipore Corp.).
RESULTS

Peptide Sequencing and Identification of Corresponding EST
Sequences-The amino acid composition and molecular weight for eIF2A purified from rabbit reticulocyte lysate were available (1); however, no peptide sequence analysis had been performed for eIF2A. Initial attempts to sequence eIF2A by Edman degradation failed suggesting the N terminus was blocked and therefore internal sequencing was required. Purified eIF2A was subjected to SDS-PAGE analysis. The 65-kDa molecular mass band was excised and subjected to digestion by trypsin. The resulting tryptic fragments were removed from the gel by diffusion and subjected to sequence determination by tandem mass spectrometry as described under "Materials and Methods." Of the recovered tryptic fragments from the 65-kDa protein, the sequence for eight peptides was obtained (Fig. 1A) . Leucine and isoleucine are indistinguishable by mass; thus these amino acids are assigned only upon identification of the peptide sequences in the data base.
None of the eight peptides were identified in any protein data base; however, all 8 were found encoded by sequences in the Expressed Sequence Tag (EST) Library (Fig. 1A) . Peptides A-D were encoded by the sequence in EST 327130, EST 114013 encoded peptides E-G, and peptide H was encoded by clone AAADMFE. The EST clones were obtained from American Type Culture Collection, and the inserts were sequenced. Once the inserts were sequenced, overlapping regions were identified allowing a complete sequence to be deduced from the three clones. The coding sequence for the entire protein including a poly(A) tail addition signal is shown in Fig. 1B with the initiating AUG and the polyadenylation sequences underlined. This sequence codes for a 585-amino acid protein with a molecular mass of 65,095 daltons. Of the 85 amino acids sequenced, over 98% are identical to the human sequence (84 of 85 are identical). The one difference is an asparagine in the 114013 EST sequence in place of a threonine in peptide G. This asparagine is found at amino acid 20 in Fig. 1B .
The sequence presented in Fig. 1B appears to contain the entire coding region although the short 5Ј sequence available does not rule out the possibility of a short N-terminal extension. As it is, the coding region for 585 amino acids yields a protein with a predicted molecular mass of 65,095 daltons, which is in agreement with previous determinations by SDS-PAGE analysis and equilibrium sedimentation centrifugation (1) . Likewise, the amino acid composition from the predicted sequence is an excellent match to that previously determined (1) as is the pI (8.9 calculated and 9.1 observed). 2 Next, for the small amount of 5Ј sequence available, the proposed initiating AUG is in a good start site context with an A at Ϫ3 and a G at ϩ4 (17) . The predicted N-terminal sequence is Met-Ala. From studies in several systems, with a complete study in yeast, this sequence is predicted to yield an N terminus of N-acetyl-Ala (18 -20) . This prediction is consistent with the lack of any signal from the native protein when subjected to amino acid sequencing.
Subsequent to our determination of the nucleotide sequences of the three EST clones, a similar sequence was found in the data base (GenBank TM accession number AF212241) for a protein termed CDA02 and described briefly as a novel gene expressed in human pheochromocytoma. This cDNA sequence extended about 70 nucleotides 5Ј of our sequence as indicated,
In this sequence, the final AC ATG GCG at the 3Ј end represents the 5Ј-terminal sequence found in our clone as well. Thus, there appear to be two, in-frame AUG codons upstream of our presumed initiating AUG. We feel that it is unlikely that these AUG codons serve as initiating codons. The first AUG codon is followed by one that would code for arginine. With arginine as the second amino acid, one would expect the N-terminal methionine to have been removed but no further modifications (18 -20) . Thus, the protein should have yielded an amino acid sequence with the intact protein. The second AUG codon is followed by one that would code for asparagine that would predict an N-acetylmethionine at the N terminus (18 -20) . Although this modification would be consistent with our sequencing results, the codon context around this AUG is poor with a U at the Ϫ3 position and an A at the ϩ4 position (this is also likely a problem for the first AUG codon as the human genome sequence predicts a C at the Ϫ3 position and an A at the ϩ4 position). Finally, as the predicted amino acid N-terminal to our proposed initiating methionine is an asparagine, one would not observe the peptide APSTPLLTVR unless protein synthesis began at the AUG codon noted in Fig. 1B (i. e. the amino acid to the N-terminal side of this peptide would have to have been an arginine or a lysine).
Besides the more extended 5Ј nucleotide sequence, there were several other differences noted in the nucleotide sequence as shown in Table I . In all, there are 14 codon differences and a single nucleotide difference in the 3Ј-untranslated region (not shown). Half of the codon changes yield the same amino acid, and most, but not all, of the remaining changes are of a conservative nature. As only a single gene was found in the search of the human genome data base, we assume these differences represent polymorphisms in the human population.
As will be noted below, the human eIF2A sequence maps to both the N and C terminus of the yeast eIF2A protein. Based on this match with either the yeast eIF2A sequence from Saccha-FIG. 1. Peptide sequences from eIF2A as determined by tandem mass spectrometry and deduced amino acid sequence. A, the tryptic peptides identified by mass spectrometry sequencing are given. For each fragment, a clone number is given that represents an EST clone containing the nucleotide sequence corresponding to the peptide sequence. B, the deduced amino acid sequence for human eIF2A determined from the nucleotide sequence of three overlapping EST clones (327130, 114013, and AAADMFE) is shown. Tryptic peptides found in the mass spectroscopic analysis are underlined. The initiating methionine, the initiating AUG, and the poly(A) addition sequence are underlined (GenBank TM accession number AF497978).
romyces cerevisiae (see below) or Schizosaccharomyces pombe and the observations cited above, there is no expectation that there is any portion of the protein sequence missing. The eIF2A Gene-By using the cDNA described above, the position of the eIF2A gene in the human genome was located on chromosome 3 with transcription heading away from the stress-associated endoplasmic reticulum protein 1 (SERP1) gene (Fig. 2) . The eIF2A mRNA is generated from 15 to 16 exons from a primary transcript that appears to be about 55 kb in size. The first identified exon is separated from the second identified exon by about 30 kb, and the remaining introns vary from about 140 to 6,000 nucleotides. Within this 30 kb would be the coding region for nucleotides 103-171 of the mRNA that were not found to match any sequence in the genome data base. However, within these 30 kb, there are patches of over 100 nucleotides where there is no sequence information. We believe that exon 2 (and perhaps exon 3) would be found in these patches.
By using the program PromoterInspector from Genomatix (www.genomatix.de), a promoter element was identified upstream of the 5Ј end of the cDNA sequence which would predict that the first nucleotide of the mRNA was about 110 nucleotides 5Ј of the initiating AUG or about 35 nucleotides 5Ј of the longest cDNA sequence (see above, GenBank TM accession number AF212241). This promoter would appear to be TATA-less and contains the housekeeping element GGGCGC. In addition to the eIF2A gene, two putative pseudogenes for eIF2A were also found. These genes are assumed to be pseudogenes as they lacked introns and were missing portions of the 5Ј end of the mRNA (5Ј-untranslated region and coding regions).
Northern Blot Analysis-To determine whether the sequence of eIF2A from the EST clones represents the full-length sequence, Northern blot analysis was performed on commercially available human tissue poly(A) ϩ mRNA blots. The EST 327130 was used to synthesize a radiolabeled probe by random priming on the excised eIF2A-encoding region. The resulting Northern blot is shown in Fig. 3 . The probe detects a single transcript of ϳ2.1 kb. This is in agreement with the length of the full sequence obtained from the overlapping EST sequences of 2104 nucleotides, although at this time, there is very little sequence 5Ј of the presumed translational start site. eIF2A is expressed in each tissue examined (Fig. 3) , although relative levels differ. eIF2A mRNA shows relatively higher expression in pancreas, heart, brain, and placenta compared with the other tissues. Compared with ␤-actin mRNA, eIF2A mRNA is particularly well expressed in pancreatic tissue. The relative expression levels reported for eIF2 and eIF5B were similar (i.e. higher in pancreas, heart, and placenta compared with brain, lung, liver, and kidney); however, eIF2 and eIF5B were also found to be highly expressed in skeletal muscle (21, 22) .
eIF2A Similarity to p116 of eIF3 and Deduced Yeast Proteins-The full-length eIF2A sequence was used to search the protein data base to identify proteins with similar sequences or 2 . The eIF2A gene. By using the cDNA sequence from AF212241, a match was made to complementary sequences in the human genome. The eIF2A sequences map to chromosome 3 as indicated in the figure. The nucleotide number in the cDNA that matches to each exon is shown where 1 is the 5Ј-terminal nucleotide and 2161 is the 3Ј-terminal nucleotide. The lack of a 100% match at each position is attributed to polymorphisms in the human tissues used to obtain either cDNA, EST, or human genome sequences. The nearest gene to the eIF2A gene is SERP1 which is several hundred nucleotides 5Ј of the eIF2A gene. The entire gene is about 55 kbp. Note that it was not possible to match nucleotides 103-170 of the cDNA to the human genome.
FIG. 3. Expression levels of eIF2A mRNA in human tissue.
Northern blot analysis of RNA from multiple human tissues probed with a radiolabeled portion of the eIF2A clone. A multiple tissue Northern blot (CLONTECH) containing 2 g of the indicated human tissue poly(A) ϩ RNA was probed with an internally labeled fragment of the eIF2A cDNA or a fragment of the human ␤-actin cDNA according to the manufacturer's instructions. motifs. The central region of eIF2A, from amino acid 90 to 415, is highly homologous (21% identity and 40% similarity) to the p116 subunit of eIF3. eIF3 is implicated in ribosome disassociation and stimulates ternary complex binding to the 40 S subunit (22, 23) . Additional searches revealed two potential homologs to eIF2A from the yeast genome data bases. The sequence of a deduced S. cerevisiae gene (YGR054W) had 28% identity (with 58% similarity) to human eIF2A, whereas a sequence deduced from a S. pombe gene had 27% identity to eIF2A. Sequence alignment showed regions with significant homology between the S. cerevisiae sequence and human eIF2A (Fig. 4) . As this identity is considerable, it is likely that these yeast genes represent the fungal homologs of eIF2A. Because this sequence is only listed as a probable open reading frame deduced from the yeast genome, no function had been ascribed to this gene. To investigate the function of the yeast eIF2A homolog, the gene encoding eIF2A in S. cerevisiae was disrupted.
eIF2A Is Encoded by a Non-essential Gene-A yeast strain disrupted in its only copy of the eIF2A gene (YGR054W) was obtained from ResGen. The resulting yeast strain, referred to as ⌬eIF2A, had a doubling time of 1.3 h, nearly identical to that of the wild type which is 1.2 h. In contrast, a ⌬eIF5B strain in the same background had a doubling time of 3.2 h. The wild type growth rate for the ⌬eIF2A strain indicates that eIF2A is not essential for growth in yeast under normal conditions. Whereas growth rates were not altered, neither the ⌬eIF2A strain nor the ⌬eIF5B strain could sporulate effectively. Growth of the eIF2A deletion strain at 13, 24, 30, and 37°C or in the presence of either cycloheximide or hygromycin also failed to show growth rates different from the wild type. An examination of the expression data base (genome-www. stanford.edu/yeast_stress/) indicates that eIF2A mRNA levels are elevated under optimal growth conditions (especially growth on glucose media) and that eIF2A mRNA levels are reduced under virtually all stress conditions (heat shock, amino acid starvation, nitrogen depletion, diauxic shift, and stationary phase, etc.).
Deletion of eIF2A Has No Effect on the Distribution of Ribosomal Subunits or
Polysomes-To determine whether the loss of eIF2A affected translation initiation, polysome profiles were compared from wild type cells, the ⌬eIF2A strain, and the ⌬eIF5B (or ⌬FUN12) strain (24) . The polysome profile from the ⌬eIF2A strain is nearly identical to wild type with similarly sized and shaped 40 S and 60 S subunits, 80 S ribosomes, and polysome peaks. In contrast, the ⌬eIF5B strain shows an almost complete loss of the 40 S subunit peak. The ⌬eIF5B strain exhibits an initiation defect as evidenced by the alteration of the polysome profile compared with that obtained with wild type cells (24) . The lack of an apparent effect of the polysomes profile suggests that under normal growth conditions initiation is not grossly affected by the loss of eIF2A in yeast.
eIF2A Is Found to Associate Specifically with 40 S Subunits and 80 S Ribosomes-In the absence of an apparent effect on translation due to eIF2A deletion, it was of interest to determine whether eIF2A actually associated with ribosomes. To determine whether eIF2A interacted with either the 40 S or 60 S subunits or polysomes, fractions from the polysome profile analysis were subjected to Western blot analysis. The coding sequence of yeast eIF2A was fused to an HA tag sequence, and then the ⌬eIF2A yeast strain was transformed with the HAtagged eIF2A (HA-eIF2A) plasmid under the control of a galactose-inducible promoter. Growth in the presence of galactose will stimulate expression of HA-tagged eIF2A, whereas growth in the presence of glucose will not result in the expression of the HA-tagged eIF2A.
Polysome profiles were compared under both growth conditions (Fig. 5, top panel) . The polysome profiles show no detectable difference between cells grown in media containing glucose versus those grown in galactose. This is consistent with the observation that the deletion of eIF2A does not alter growth rates. Samples from fractions of the polysome profile were collected, precipitated, and subjected to SDS-PAGE separation followed by Western blot analysis. Under glucose growth conditions, no HA-eIF2A was detected in the polysome profile (Fig.  5) , although there was a cross-contaminating band observed in the 1st lane, which was also observed when the yeasts were grown on galactose. Under galactose growth conditions, HAeIF2A was expressed and found to predominantly associate with 40 S and 80 S fractions.
To determine whether the small amount of HA-eIF2A in the 60 S peak was due to contamination from the 40 S peak, a 10 -25% sucrose gradient was utilized to achieve a better separation between the 40 S and 60 S ribosomal subunits. Cell extracts from the ⌬eIF2A yeast strain were subjected to separation, and the resulting polysome profile was monitored by A 260 and Western blot analysis. The 40 S and 60 S ribosomal subunits were clearly resolved in this profile, and the HA-eIF2A was detected primarily with the 40 S subunits and 80 S ribosomes (data not shown). This is in contrast to the pattern observed when the fractions are probed with an anti-eIF2 antibody. eIF2 was found in the cyto -FIG. 4 . S. cerevisiae and human eIF2A sequence alignment. The top line represents the amino acid sequence of the yeast eIF2A protein, whereas the bottom line represents the human sequence. Sequence alignment was generated using ClustalW (35) at the Pole-Bioinformatique Lyonnaise Web server (pbil.ibcp.fr). The two proteins are 27.9% identical and 58.0% similar. The yeast protein is composed of 642 amino acids and the human sequence is 585 amino acids.
solic fractions, associated with the 40 S subunit, and upon overexposure of the film, eIF2 could be detected in the polysome fraction presumably due to 40 S subunits initiating on mRNAs associated with polysomes (data not shown). This is consistent with the traditional initiation model in which eIF2 leaves the 40 S subunit upon GTP hydrolysis.
Genetic Interaction of eIF2A and eIF5B-Given the lack of an apparent phenotype other than a reduced ability of the ⌬eIF2A diploid strain to sporulate, an attempt was made to study interactions of eIF2A with other factors genetically. A logical candidate was eIF5B for two reasons. First, eIF5B is known to interact with eIF2A in the process of 80 S complex formation using AUG codon (see Introduction). Second, the ⌬eIF5B strain is viable although it has a slow growth phenotype. A cross of these two strains could have one of the following outcomes: the cells would grow with wild type growth rates (because there was no eIF2A, eIF5B would not be required to catalyze its release from 40 S complexes); the growth rate would be slowed as was observed with the ⌬eIF5B strain (the activity of eIF5B would be unrelated to eIF2A function); there would be no growth (eIF5B and eIF2A function in the same pathway and thus this generates a synthetic lethal).
An analysis of the tetrads resulting from this cross is presented in Fig. 6 . As can be seen, two types of results were obtained. In one group of tetrads, both the wild type and ⌬eIF2A strains grew at about the same rate; the ⌬eIF5B strain grew more slowly and the double mutant (⌬eIF2A, ⌬eIF5B) grew even more slowly (lanes 2, 3, and 5) . For the second group of tetrads, the wild type grew at the usual rate, but the ⌬eIF2A strain grew somewhat more slowly; the ⌬eIF5B strain grew more slowly than the ⌬eIF2A strain, and the double mutant barely grew at all (lanes 1, 4, 6, 7, and 8) . This was confirmed by comparing the growth rates of 5 randomly selected double knockouts to the growth of the original eIF5B knockout, the eIF2A knockout, and the wild type BY4743 strains. The doubling times were 5.2 Ϯ 0.5, 3.2 Ϯ 0.3, 1.4 Ϯ 0.2, and 1.35 Ϯ 0.2 h, respectively. Thus, in both sets of tetrads, the double mutant was "synthetically sick" (as opposed to synthetically lethal) implying that both proteins lie in the same functional pathway. We anticipate that the two different types of tetrads are the result of crossing non-isogenic strains. Dr. T. Dever (NICHD, National Institutes of Health) has observed that a number of translation mutants (factors, ribosomal proteins, etc.) are synthetically sick when combined with the eIF5B knockout. 3 This provides additional evidence of the association of eIF2A with the translation initiation pathway but makes more tenuous the direct interaction of eIF2A and eIF5B or steps containing eIF2A with steps requiring eIF5B.
Effect of eIF2A on Re-initiation-During re-initiation, the ribosome is already on the mRNA, and a ternary complex must bind to the 40 S subunit to allow initiation to occur at a downstream ORF. GCN4 expression is controlled by re-initiation in yeast (25) . Amino acid starvation conditions lead to the upregulation of GCN4 by a decrease in ternary complex availability. A set of mutations (referred to as GCD mutants) leads to the up-regulation of GCN4 in the absence of amino acid starvation conditions or GCN2 activation. Each of the three eIF2 subunits and four of the eIF2B subunits can be mutated to increase GCN4 expression providing strong evidence that eIF2 is involved in re-initiation (26) .
To test whether eIF2A might be associated with re-initiation, we obtained from Dr. T. Dever the clones appropriate for testing for GCN4 expression under conditions of amino acid star-3 T. Dever, personal communication.
FIG. 5.
Polysome profile and Western blot analysis of ⌬eIF2A strains transformed with an HA-tagged eIF2A clone. Extracts from ⌬eIF2A yeast strains carrying a plasmid encoding the wild type HA-eIF2A under control of a galactose-inducible promoter were subjected to sucrose gradient (10 -50%) centrifugation. Cells grown in glucose-containing or galactose-containing media were analyzed, and the profiles were nearly identical (top panel). Each fraction from the gradient was precipitated with 10% trichloroacetic acid, resuspended in SDS sample buffer, and subjected to electrophoresis. Subsequently, proteins were transferred to Immobilon membranes and probed with antibodies to the HA epitope (middle and bottom panels). A crosscontaminating band is observed in the cytosolic fraction from extracts of cells grown in glucose and galactose. FIG. 6 . Tetrad analysis of a cross between ⌬eIF2A and ⌬eIF5B strains of yeast. The X (J140) and Y (BY4742) haploid strains were mated and sporulated. Following dissection, tetrads were phenotyped by replica plating to determine the segregation of the leu Ϫ (⌬eIF5B) and kan ϩ (⌬eIF2A) phenotypes. ⌬⌬ designates the ⌬eIF2A⌬eIF5B phenotype, and wt designates wild type. The numbers below each lane correspond the individual tetrads randomly picked for analysis. vation (15) . As can be seen in Fig. 7 , the eIF2A deletion strain appears to allow for the same level of increase in GCN4-lacZ expression with amino acid starvation as seen with the wild type cells (Fig. 7, p180 ). This is also true for the p196 construct that contains two of the four small upstream ORFs. When only the final small ORF is present (p226 construct), there is no induction of GCN4-lacZ in either wild type cells or in the eIF2A knockout strain. As was noted previously, when all of the upstream ORFs were deleted (p227 construct), the expression of GCN4-lacZ increases about 10-fold above the level seen with amino acid starvation. This induction is about 15-fold in the eIF2A deletion strain. The mechanistic basis for this increased induction over what is seen in the wild type cells is unknown.
DISCUSSION
In this study, a number of tryptic peptides from rabbit reticulocyte eIF2A have been used to determine the coding sequence for the protein. From the data base, three ESTs were identified that corresponded to the amino acid sequences determined by mass spectroscopy. The inserts were sequenced, and an mRNA sequence was generated that encoded what appears to represent the entire amino acid sequence for eIF2A (Fig. 1B) . The mRNA is about 2100 nucleotides from the 5Ј end to the poly(A) tail. The size of either our nucleotide sequence (GenBank TM accession number AF497978) or that from the data base (GenBank TM accession number AF212241) is consistent with the size of the eIF2A mRNA determined by Northern blots to be about 2.1 kb (Fig. 3) .
From homology searches, a homolog in yeast to eIF2A was identified. The coding region in yeast had not been characterized, but from knockout studies, it was known that the yeast null eIF2A mutant was viable. However, when tested for sporulation, the ⌬eIF2A mutant strain showed reduced sporulation. The lack of a polysome profile defect in the null mutant suggests that the general initiation pathway was not affected by the loss of eIF2A (Fig. 5) . HA-tagged eIF2A was shown to be associated with the 40 S subunits, which is consistent with its activity as an initiation factor (Fig. 5) . The association of eIF2A with 80 S ribosomes is unusual for initiation factors as most are released prior to 60 S subunit joining. Because eIF2A is not found in the polysome fraction, it is unlikely to be a ribosomal protein. Therefore, eIF2A must cycle off the ribosome sometime after subunit joining but prior to polysome formation. This would suggest that eIF2A acts late in the initiation pathway or during the translation of the first few amino acids. eIF5A is thought to function in a similar manner, in that it stimulates a step late in initiation, after subunit joining, and is believed to act at the synthesis of the first peptide bond (7, 23) .
Because it was not possible to quantify the amount of eIF2A relative to the number of ribosomes, the stoichiometry of their interaction is unknown. eIF2A may be present on each 40 S subunit or on just a subset (by comparison of A 260 (40 S and 80 S), and it is clear that eIF2A is present only on a subset of the 80 S ribosomes). If eIF2A were present on each free 40 S subunit, this would suggest a general function in translation. The presence of eIF2A on a fraction of the 40 S subunits could suggest specificity in binding, perhaps leading to a preferential enhancement or silencing of a given reading frame. Thus, eIF2A might act as a regulator of translation. The most obvious question would then be, which mRNAs are regulated?
The identification and cloning of three factors (eIF2, eIF2A, and eIF5B) capable of binding the initiator tRNA raises numerous questions (1, 7, 24) . Because eIF2 is essential for growth in yeast (26 -28) and appears to be the physiologically relevant initiator tRNA binding factor, what is the role of eIF5B and eIF2A in initiation? Does either protein bind initiator tRNA in a physiologically relevant manner? Could eIF2A or eIF5B act alone or in concert with eIF2 for alternative initiation events? The polysome profile defects observed for the ⌬eIF5B strains argue for a general initiation event activity for this protein. However, for eIF2A, the polysome profiles were not visibly altered upon deletion of eIF2A. One possibility is that eIF2A does not function in the initiation of translation of bulk mRNAs but rather is involved in a small subset of mRNA initiation events. These alternative initiation events could include re-initiation, internal initiation, or non-AUG initiation.
As noted under "Results," eIF2A does not appear to influence FIG. 7 . Expression of reporter GCN4-lacZ constructs under the control of GAL1 promoter. Plasmids were transformed into wild type BY4741 and isogenic eIF2AD strains. Sulfometuron methyl elicits amino acid starvation by blocking the de novo synthesis of the branched chain amino acids. ␤-Galactosidase activity (units) are shown (measured as described in CLONTECH Yeast Protocols Handbook).
re-initiation, at least as tested using the GCN4 reporter system.
Internal initiation, like re-initiation, is an alternative initiation event in which the 40 S subunit might be bound to the mRNA before eIF2 (or another initiation factor) and initiator tRNA would bind to it. This is reminiscent of the prokaryotic scheme, and because eIF2A has activity similar to that of prokaryotic IF2, eIF2A could play a role in internal initiation. Based upon recent estimates, it would appear that cellular mRNAs that use internal initiation are rare (2-3% of the total) and that in general their utilization is dramatically up-regulated under conditions of stress (29) . If eIF2A were functioning in internal initiation, it is likely that one would observe no phenotype under the growth conditions used here.
Genetic studies in yeast have shown that recognition of the initiating AUG is accomplished via an interaction between the AUG codon and the anti-codon of the initiator tRNA, MettRNA i (30) . For non-AUG initiation in yeast, a class of mutants has been described as suppressor of initiation (SUI) mutants, which allow initiation to occur at non-AUG sites. Three of the SUI mutants encode eIF2 subunits, and eIF5 (the 60-kDa, GTPase-stimulating protein) also appears as a SUI mutant (26, 27, 31, 32) . Because eIF2 is known to bind only the initiator tRNA, the traditional initiation event must be altered to allow non-AUG initiation. If the start codon is not AUG, then the initiator tRNA cannot form the appropriate base pairs (note: in almost all instances studied, non-AUG initiating codons direct incorporation of methionine suggesting an altered use of initiation factors, as with the SUI mutants; Ref. 33) . Alteration in the subunits of translation initiation factors (i.e. the SUI mutants, see Ref. 34) or increases in eIF2 GTPase activity caused by mutant eIF5 proteins enhance the ability of the initiator tRNA to initiate at either non-AUG codons or at inappropriate AUG codons (32) . The alternative possibility would be that in some manner either the presence or the absence of eIF2A and/or eIF5B might allow for facilitated initiation at non-AUG codons. Additional experimentation will be required to determine whether this might be the primary function for eIF2A.
